Lukas Mendes de Abreu DDS, MS, Mariel Ruivo Biancardi DDS, MS, Michele Di Benedetto DDS, Raquel Molina Sanches DDS, Camila Lopes Cardoso DDS, MS, PhD, Cássia Maria Fischer Rubira DDS, MS, PhD, Izabel Regina Fischer Rubira-Bullen DDS, MS, PhD
{"title":"大麻二酚在口腔疾病中的治疗潜力","authors":"Lukas Mendes de Abreu DDS, MS, Mariel Ruivo Biancardi DDS, MS, Michele Di Benedetto DDS, Raquel Molina Sanches DDS, Camila Lopes Cardoso DDS, MS, PhD, Cássia Maria Fischer Rubira DDS, MS, PhD, Izabel Regina Fischer Rubira-Bullen DDS, MS, PhD","doi":"10.1016/j.adaj.2025.07.021","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>This review aimed to evaluate the therapeutic potential of cannabidiol (CBD) for management of oral disorders, focusing on its effectiveness in treatment (therapy) of orofacial pain, inflammation, and mucosal lesions.</div></div><div><h3>Types of Studies Reviewed</h3><div>This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. A comprehensive search in 5 databases included randomized controlled trials and nonrandomized trials evaluating CBD’s clinical effects on oral disorders. Inclusion criteria were applied independently by 2 reviewers using predefined eligibility parameters.</div></div><div><h3>Results</h3><div>Of 4,093 records, 7 studies met inclusion criteria: 6 randomized controlled trials and 1 nonrandomized clinical study. Topical and intraoral CBD formulations had beneficial effects in reducing pain, muscle tension, gingival inflammation, bacterial load, and aphthous ulcer symptoms. No serious adverse effects were reported. Heterogeneity in dosage, formulation, follow-up duration, and outcome measures limited direct comparison across studies and precluded meta-analysis.</div></div><div><h3>Practical Implications</h3><div>CBD may serve as a safe adjunct in managing oral pain and inflammation. Its integration into dental care protocols requires further validation through standardized, long-term clinical trials to ensure efficacy and safety.</div></div>","PeriodicalId":17197,"journal":{"name":"Journal of the American Dental Association","volume":"156 10","pages":"Pages 838-850.e2"},"PeriodicalIF":3.5000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Therapeutic potential of cannabidiol in oral disorders\",\"authors\":\"Lukas Mendes de Abreu DDS, MS, Mariel Ruivo Biancardi DDS, MS, Michele Di Benedetto DDS, Raquel Molina Sanches DDS, Camila Lopes Cardoso DDS, MS, PhD, Cássia Maria Fischer Rubira DDS, MS, PhD, Izabel Regina Fischer Rubira-Bullen DDS, MS, PhD\",\"doi\":\"10.1016/j.adaj.2025.07.021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>This review aimed to evaluate the therapeutic potential of cannabidiol (CBD) for management of oral disorders, focusing on its effectiveness in treatment (therapy) of orofacial pain, inflammation, and mucosal lesions.</div></div><div><h3>Types of Studies Reviewed</h3><div>This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. A comprehensive search in 5 databases included randomized controlled trials and nonrandomized trials evaluating CBD’s clinical effects on oral disorders. Inclusion criteria were applied independently by 2 reviewers using predefined eligibility parameters.</div></div><div><h3>Results</h3><div>Of 4,093 records, 7 studies met inclusion criteria: 6 randomized controlled trials and 1 nonrandomized clinical study. Topical and intraoral CBD formulations had beneficial effects in reducing pain, muscle tension, gingival inflammation, bacterial load, and aphthous ulcer symptoms. No serious adverse effects were reported. Heterogeneity in dosage, formulation, follow-up duration, and outcome measures limited direct comparison across studies and precluded meta-analysis.</div></div><div><h3>Practical Implications</h3><div>CBD may serve as a safe adjunct in managing oral pain and inflammation. Its integration into dental care protocols requires further validation through standardized, long-term clinical trials to ensure efficacy and safety.</div></div>\",\"PeriodicalId\":17197,\"journal\":{\"name\":\"Journal of the American Dental Association\",\"volume\":\"156 10\",\"pages\":\"Pages 838-850.e2\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Dental Association\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0002817725004787\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Dental Association","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002817725004787","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
Therapeutic potential of cannabidiol in oral disorders
Background
This review aimed to evaluate the therapeutic potential of cannabidiol (CBD) for management of oral disorders, focusing on its effectiveness in treatment (therapy) of orofacial pain, inflammation, and mucosal lesions.
Types of Studies Reviewed
This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. A comprehensive search in 5 databases included randomized controlled trials and nonrandomized trials evaluating CBD’s clinical effects on oral disorders. Inclusion criteria were applied independently by 2 reviewers using predefined eligibility parameters.
Results
Of 4,093 records, 7 studies met inclusion criteria: 6 randomized controlled trials and 1 nonrandomized clinical study. Topical and intraoral CBD formulations had beneficial effects in reducing pain, muscle tension, gingival inflammation, bacterial load, and aphthous ulcer symptoms. No serious adverse effects were reported. Heterogeneity in dosage, formulation, follow-up duration, and outcome measures limited direct comparison across studies and precluded meta-analysis.
Practical Implications
CBD may serve as a safe adjunct in managing oral pain and inflammation. Its integration into dental care protocols requires further validation through standardized, long-term clinical trials to ensure efficacy and safety.
期刊介绍:
There is not a single source or solution to help dentists in their quest for lifelong learning, improving dental practice, and dental well-being. JADA+, along with The Journal of the American Dental Association, is striving to do just that, bringing together practical content covering dentistry topics and procedures to help dentists—both general dentists and specialists—provide better patient care and improve oral health and well-being. This is a work in progress; as we add more content, covering more topics of interest, it will continue to expand, becoming an ever-more essential source of oral health knowledge.